Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 313Leukemia 119Lymphoma 108Lymphoma, Follicular 104Lymphoma, Non-Hodgkin 102Precursor Cell Lymphoblastic Leukemia-Lymphoma 90Lymphoma, B-Cell, Marginal Zone 90Lymphoma, Mantle-Cell 78Lymphoma, Large B-Cell, Diffuse 67Burkitt Lymphoma 61Waldenstrom Macroglobulinemia 47Lymphoma, Large-Cell, Immunoblastic 38Hodgkin Disease 33Myelodysplastic Syndromes 24Leukemia, Myeloid, Acute 24Hematologic Neoplasms 22Leukemia, Hairy Cell 20Recurrence 19Multiple Myeloma 18Lymphoma, B-Cell 18Leukemia, Prolymphocytic 16Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, Large-Cell, Anaplastic 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Leukemia, B-Cell 11Intraocular Lymphoma 11Leukemia, Myelomonocytic, Chronic 10Leukemia, Myeloid, Accelerated Phase 10Neoplasms, Plasma Cell 9Lymphoma, T-Cell, Cutaneous 9

Interventions

glucarpidase 2ripretinib 1pevonedistat 1gamma-Glutamyl Hydrolase 1belinostat 1Rituximab 1Methotrexate 1Leucovorin 1Lenalidomide 1Cyclophosphamide 1Carboxypeptidases 1Bendamustine Hydrochloride 1Azacitidine 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Renal Insufficiency × Rituximab × Other hematologic neoplasm × Clear all
NCT01832922 2018-03-30

BR in Patients With CLL With Comorbidities and/or Renal Dysfunction

Dartmouth-Hitchcock Medical Center

Phase 1 Completed
8 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡